The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi'an, China between 1999 and 2009

International Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages

  Ji, Zhao Hua ^a   Li, Cui Ying ^b   Lv, Yong Gang ^a   Cao, Wei ^c   Chen, Yao Zhen ^d   Chen, Xiao Peng ^d   Tian, Min ^a   Li, Jing Hua ^d   An, Qun Xing ^d   Shao, Zhong Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Blood borne pathogens; Hepatitis; Human immunodeficiency virus; Syphilis; Transfusion

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CHINA; DISEASE MARKER; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT TREPONEMA ANTIBODY TEST; GROUPS BY AGE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; MALE; PREVALENCE; SYPHILIS; TREPONEMA PALLIDUM; WESTERN BLOTTING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; CHINA; COMMUNICABLE DISEASES; DISEASE TRANSMISSION, INFECTIOUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEX FACTORS;

EID: 84875370810     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.10.006     Document Type: Article

References (28)

1. Heiden R.S. Quality and safety in blood supply in 2010. Transfus Med Hemother 2010, 37:112-117.
2. Su B., Liu L., Wang F., Gui X., Zhao M., Tien P., et al. HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003, 17:2515.
3. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567.
4. Shang G., Seed C.R., Wang F., Nie D., Farrugia A. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007, 47:529-539.
5. Shan H., Wang J.X., Ren F.R., Zhang Y.Z., Zhao H.Y., Gao G.J., et al. Blood banking in China. Lancet 2002, 360:1770-1775.
6. Kafi-abad S.A., Rezvan H., Abolghasemi H., Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009, 49:2214-2220.
7. Chan J.M., Oh W.K., Xie W., Regan M.M., Stampfer M.J., King I.B., et al. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol 2009, 27:3577-3583.
8. Nguyen S.H., Dang T.P., MacPherson C., Maibach H., Maibach H.I. Prevalence of patch test results from 1970 to 2002 in a multi-centre population in North America (NACDG). Contact Dermatitis 2008, 58:101-106.
9. Lai J.S., Cook K., Stone A., Beaumont J., Cella D. Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periods. J Clin Epidemiol 2009, 62:991-997.
10. Glynn S.A., Kleinman S.H., Schreiber G.B., Busch M.P., Wright D.J., Smith J.W., et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA 2000, 284:229.
11. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27:6550-6557.
12. Garten R.J., Lai S., Zhang J., Liu W., Chen J., Vlahov D., Yu X.F. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 2004, 33:182.
13. Chen Y.D., Liu M.Y., Yu W.L., Li J.Q., Peng M., Dai Q., et al. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis Int 2002, 1:194-201.
14. He N., Detels R. The HIV epidemic in China: history, response, and challenge. Cell Res 2005, 15:825-832.
15. Soldan K., Barbara J., Ramsay M., Hall A. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 2003, 84:274-286.
16. Zou S., Notari E.P., Stramer S.L., Wahab F., Musavi F., Dodd R.Y. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004, 44:1640-1647.
17. Gurol E., Saban C., Oral O., Cigdem A., Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006, 21:299-305.
18. Singh B., Verma M., Verma K. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis 2004, 57:49-51.
19. Chiavetta J.A., Escobar M., Newman A.M., He Y., Driezen P., Deeks S., et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003, 169:767.
20. Zhao S.M., Jiang T.L., Li R.Q., Gao F., Lu L., Zheng H., et al. HCV infection in voluntary donors and its influence on recruitment of donors in Chongqing area. Journal of Experimental Hematology/Chinese Association of Pathophysiology 2008, 16:676-680.
21. Linjun H., Chaohun Z., Yuanlong L. Analysis of unpaid blood donors infected with hepatitis C virus and syphilis. Chinese Journal of Health Laboratory Technology 2007, 17:938-939.
22. Mingyi Y. Distribution and epidemiological trend of anti-HCV among free blood donors in Changsha city. Practical Preventive Medicine 2002, 9:132-133.
23. Xia G.L., Liu C.B., Cao H.L., Bi S.L., Zhan M.Y., Su C.A., et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. International Hepatology Communications 1996, 5:62-73.
24. Sheng L., Cao W.K. HIV/AIDS epidemiology and prevention in China. Chin Med J (Engl) 2008, 121:1230-1236.
25. Likatavicius G., Hamers F.F., Downs A.M., Alix J., Nardone A. Trends in HIV prevalence in blood donations in Europe, 1990-2004. AIDS 2007, 21:1011.
26. Tucker J.D., Chen X.S., Peeling R.W. Syphilis and social upheaval in China. N Engl J Med 2010, 362:1658-1661.
27. Chen Z.Q., Zhang G.C., Gong X.D., Lin C., Gao X., Liang G.J., et al. Syphilis in China: results of a national surveillance programme. Lancet 2007, 369:132-138.
28. Ministry of Health of the People's Republic of China. Chinese health statistical digest. Beijing: Ministry of Health; 2010.